Article Cited by others


Expedited drug review process: Fast, but flawed

Chary Krishnan Vengadaraga

Year : 2016| Volume: 7| Issue : 2 | Page no: 57-61

   This article has been cited by
1 Recent advances in precision oncology research
Ann M. Bode,Zigang Dong
npj Precision Oncology. 2018; 2(1)
[Pubmed]  [Google Scholar] [DOI]
2 The US Food and Drug Administration’s expedited approval programs: Addressing premarket flexibility with enhanced postmarket evidence generation
Joshua D Wallach,Joseph S Ross,Huseyin Naci
Clinical Trials. 2018; 15(3): 243
[Pubmed]  [Google Scholar] [DOI]
3 “Fast Track” Development and Approval Process for Heart Failure Therapeutics
L Papadimitriou,J Butler
Clinical Pharmacology & Therapeutics. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article